Patients infected with SARS-CoV-2 develop protective immune responses mediated by virus-specific T cells and antibodies shortly after infection. However, there is concern that immunity will wane, resulting in severe COVID-19 infection upon re-infection.
Anna Martner and colleagues from the University of Gothenburg publish two key results in the Proceedings of the National Academy of Sciences on July 12. (PNAS). Initially, numerous virus-specific T cell variations were discovered in blood soon after COVID-19 but subsequently disappeared within 10-12 weeks. However, in the blood of all previously SARS-CoV-2-infected individuals, a fraction of highly specialised T cells, which are meant to assist destroy infected cells, remained active. These T cells did not vanish or diminish even after an extended period of monitoring.
Also Read: Use of anti-inflammatory drug in treating patients with severe COVID-19 may lower risk of death
The findings might explain why people infected with SARS-CoV-2 again have a decreased risk of severe illness and death.
Researchers from the University of Gothenburg and Sahlgrenska University Hospital gathered 81 blood samples from hospital staff members who had moderate COVID-19 in the first year of the pandemic, as well as uninfected controls, during the first year of the epidemic. T cell reactivity to an inner component of SARS-CoV-2 (the virus nucleocapsid) was investigated, capturing T cell responses that occur only after a natural infection.
Blood samples were given over 100 peptides from the nucleocapsid component of the SARS-CoV-2 virus. The researchers next examined which T cell mediators (cytokines) were created by blood cells to determine the duration of T cell responsiveness following infection.
It was observed that a subgroup of specialized T cells (Th1 cells) that promote the destruction of virus-infected cells were active for at least 20 months after natural COVID-19. The infected patients also harboured several other types of T cells that reacted with SARS-CoV-2. These latter T cells disappeared from blood approximately 2 months after recovery from infection.
“While certain subsets of T cells disappear shortly after an infection, highly specialized T cells (T helper 1 cells) remain stably present in the blood to suggest that a vital aspect of protective immunity is functional years after COVID-19,” says Anna Martner, Associate Professor of Immunology at the Sahlgrenska Academy. These results may explain why re-infection with SARS-CoV-2 only rarely translates into severe COVID-19.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…